The Supreme Court's decision in Wyeth v. Levine could lead the FDA to require excessive warnings on medications and impose "contraindications" that would constrain medical practice.

The U.S. Supreme Court recieved an amicus brief on FDA regulation.

The Supreme Court's Wyeth decision will hurt new drug development and limit physicians' willingness to use certain drugs.

The Supreme Court's decision in Wyeth v. Levine will be negative for patient welfare.

The Supreme Court has declared open season on American manufacturers.

In its Wyeth decision, the Supreme Court has gutted "federal preemption," one of the few remaining protections against state interference in the national economy.

Abuse of the tort system by trial lawyers is driving safe drugs from the market and patients from mainstream medicine.

The federal preemption of state tort law is an issue in several cases on the Supreme Court’s docket, including February 25 oral arguments in Warner-Lambert v. Kent. The Supreme Court also recently agreed to hear early next term appeals in the cases of Wyeth v. Levine, in which the federal...